44 total articles - Page 3 of 5
Do magic mushrooms have ‘strains’ like cannabis?
Nick Jikomes, PhD - Published on April 28, 2022Read moreKnow what you’re dosing: Different species and strains can have dramatically different levels of psilocybin, the hallucinogenic compound.
Is CBD an antiviral COVID drug?
Nick Jikomes, PhD - Published on March 24, 2022Read moreDr. Martha Roser, author of a headline-making study, talks about the promise and limitations of her findings.
Can drug use make you lose your mind?
Nick Jikomes, PhD - Published on February 28, 2022Read moreDrug-induced psychosis is a real thing. But which drugs? At what dosage? All these variables matter.
What are the potential risks of microdosing psychedelics?
Nick Jikomes, PhD - Published on January 20, 2022Read moreMicrodosing psychedelics has become a popular wellness trend, but is it really that beneficial? Learn more on the science of how much you take and how often you take psychedelics.
Is your drug a psychedelic, a dissociative, or an empathogen?
Nick Jikomes, PhD - Published on December 14, 2021Read moreKetamine affects the brain differently than ecstasy or psilocybin. Why? The answer lies in each drug’s chemical structure.
Would psychedelic therapy work without tripping?
Nick Jikomes, PhD - Published on November 2, 2021Read moreWhen psychedelic medicine is effective, is it pure chemistry—or is the experience of the trip essential?
Death and psychedelics: How science is reviving this ancient connection
Nick Jikomes, PhD - Published on October 5, 2021Read moreNew research finds psychedelics can ease our fear of death. But the connections between the mind and mortality stretch back thousands of years.
Leafly Insights: What CBD Strains & Products Are Consumers Looking For?
Nick Jikomes, PhD - Published on November 15, 2018Read moreWe dug into the data to find out how cannabis consumer demands have shifted in the last year. Spoiler alert: They want more CBD.
Cannabis Study: How THC Affects Learning and Memory at Different Ages
Nick Jikomes, PhD - Published on June 13, 2017Read moreA 2017 study looked at the impact of THC on memory in young vs. older mice. Learn more about the findings and what it could mean for future research.
Rick Doblin of MAPS Talks Medical Cannabis Trials and a Possible Legalization Timeline
Nick Jikomes, PhD - Published on May 18, 2017Read moreWe caught up with Rick Doblin to discuss MAPS-funded medical cannabis clinical trials and his thoughts on the end of federal prohibition.